35s
enGene Maps BLA by End-2026, Targets 2027 Launch for Lead NMIBC Therapy at Oppenheimer Conference
Chief Executive Officer Ron Cooper outlined the company’s near-term regulatory and clinical plans for its lead program, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results